Improving Standard Therapies

Dr. Brad Nelson (2003 and 2004 Research Grants)

Dr. Brad Nelson’s research hopes to improve popular prostate cancer treatments like hormone therapy and radiation. In March 2007, he published a study that showed for the first time that, in addition to fighting cancer themselves, these therapies also stimulate the body’s own immune system to fight tumours.

Dr. Nelson identified 21 specific antigens that are released by prostate tumours and attacked by the immune system. He is now using these antigens to develop a drug that can improve the immune-friendly effects of radiation and hormone therapy. Ultimately, this drug – which would be given to men before treatment - could be a cost effective way of making therapy more effective and help men live longer.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More

Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More


Click here for news archive